AIM: Grapefruit-seed extract (GSE) containing flavonoids, possesses antibacterial and antioxidative properties but whether it influences the gastric defense mechanism and gastroprotection against ethanol- and stress-induced gastric lesions remains unknown. METHODS: We compared the effects of GSE on gastric mucosal lesions induced in rats by topical application of 100% ethanol or 3.5 h of water immersion and restraint stress (WRS) with or without (A) inhibition of cyclooxygenase (COX)-1 activity by indomethacin and rofecoxib, the selective COX-2 inhibitor, (B) suppression of NO-synthase with L-NNA (20 mg/kg ip), and (C) inactivation by capsaicin (125 mg/kg sc) of sensory nerves with or without intragastric (ig) pretreatment with GSE applied 30 min prior to ethanol or WRS. One hour after ethanol and 3.5 h after the end of WRS, the number and area of gastric lesions were measured by planimetry, the gastric blood flow (GBF) was assessed by H2-gas clearance technique and plasma gastrin levels and the gastric mucosal generation of PGE2, superoxide dismutase (SOD) activity and malonyldialdehyde (MDA) concentration, as an index of lipid peroxidation were determined. RESULTS: Ethanol and WRS caused gastric lesions accompanied by the significant fall in the GBF and SOD activity and the rise in the mucosal MDA content. Pretreatment with GSE (8-64 mg/kg i g) dose-dependently attenuated gastric lesions induced by 100% ethanol and WRS; the dose reducing these lesions by 50% (ID50) was 25 and 36 mg/kg, respectively, and this protective effect was similar to that obtained with methyl PGE2 analog (5 microg/kg i g). GSE significantly raised the GBF, mucosal generation of PGE2, SOD activity and plasma gastrin levels while attenuating MDA content. Inhibition of PGE2 generation with indomethacin or rofecoxib and suppression of NO synthase by L-NNA or capsaicin denervation reversed the GSE-induced protection and the accompanying hyperemia. Co-treatment of exogenous calcitonine gene-related peptide (CGRP) with GSE restored the protection and accompanying hyperemic effects of GSE in rats with capsaicin denervation. CONCLUSION: GSE exerts a potent gastroprotective activity against ethanol and WRS-induced gastric lesions via an increase in endogenous PG generation, suppression of lipid peroxidation and hyperemia possibly mediated by NO and CGRP released from sensory nerves.
AIM: Grapefruit-seed extract (GSE) containing flavonoids, possesses antibacterial and antioxidative properties but whether it influences the gastric defense mechanism and gastroprotection against ethanol- and stress-induced gastric lesions remains unknown. METHODS: We compared the effects of GSE on gastric mucosal lesions induced in rats by topical application of 100% ethanol or 3.5 h of water immersion and restraint stress (WRS) with or without (A) inhibition of cyclooxygenase (COX)-1 activity by indomethacin and rofecoxib, the selective COX-2 inhibitor, (B) suppression of NO-synthase with L-NNA (20 mg/kg ip), and (C) inactivation by capsaicin (125 mg/kg sc) of sensory nerves with or without intragastric (ig) pretreatment with GSE applied 30 min prior to ethanol or WRS. One hour after ethanol and 3.5 h after the end of WRS, the number and area of gastric lesions were measured by planimetry, the gastric blood flow (GBF) was assessed by H2-gas clearance technique and plasma gastrin levels and the gastric mucosal generation of PGE2, superoxide dismutase (SOD) activity and malonyldialdehyde (MDA) concentration, as an index of lipid peroxidation were determined. RESULTS:Ethanol and WRS caused gastric lesions accompanied by the significant fall in the GBF and SOD activity and the rise in the mucosal MDA content. Pretreatment with GSE (8-64 mg/kg i g) dose-dependently attenuated gastric lesions induced by 100% ethanol and WRS; the dose reducing these lesions by 50% (ID50) was 25 and 36 mg/kg, respectively, and this protective effect was similar to that obtained with methyl PGE2 analog (5 microg/kg i g). GSE significantly raised the GBF, mucosal generation of PGE2, SOD activity and plasma gastrin levels while attenuating MDA content. Inhibition of PGE2 generation with indomethacin or rofecoxib and suppression of NO synthase by L-NNA or capsaicin denervation reversed the GSE-induced protection and the accompanying hyperemia. Co-treatment of exogenous calcitonine gene-related peptide (CGRP) with GSE restored the protection and accompanying hyperemic effects of GSE in rats with capsaicin denervation. CONCLUSION: GSE exerts a potent gastroprotective activity against ethanol and WRS-induced gastric lesions via an increase in endogenous PG generation, suppression of lipid peroxidation and hyperemia possibly mediated by NO and CGRP released from sensory nerves.
Authors: T Brzozowski; P C Konturek; S J Konturek; Z Sliwowski; D Drozdowicz; J Stachura; R Pajdo; E G Hahn Journal: Eur J Pharmacol Date: 1999-11-26 Impact factor: 4.432
Authors: R J Nijveldt; E van Nood; D E van Hoorn; P G Boelens; K van Norren; P A van Leeuwen Journal: Am J Clin Nutr Date: 2001-10 Impact factor: 7.045
Authors: Tomasz Brzozowski; Piotr C Konturek; Stanislaw J Konturek; Slawomir Kwiecień; Zbigniew Sliwowski; Robert Pajdo; Alexandra Duda; Agata Ptak; Eckhart G Hahn Journal: Int J Colorectal Dis Date: 2003-01-18 Impact factor: 2.571
Authors: S Kwiecień; T Brzozowski; P C Konturek; M W Pawlik; W W Pawlik; N Kwiecień; S J Konturek Journal: J Physiol Pharmacol Date: 2004-06 Impact factor: 3.011
Authors: Amy Fakhry Boushra; Asmaa Mohammed Elsayed; Noha Abdellatif Ibrahim; Maha Khaled Abdelwahed; Eman Ibrahim Ahmed Journal: Mol Biol Rep Date: 2019-07-11 Impact factor: 2.316
Authors: Ibrahim Abdel Aziz Ibrahim; Yusof Kamisah; Mohd Ismail Nafeeza; Mohd Fahami Nur Azlina Journal: Arch Med Sci Date: 2012-02-29 Impact factor: 3.318
Authors: Nylane Maria Nunes de Alencar; Rachel Sindeaux Paiva Pinheiro; Ingrid Samantha Tavares de Figueiredo; Patrícia Bastos Luz; Lyara Barbosa Nogueira Freitas; Tamiris de Fátima Goebel de Souza; Luana David do Carmo; Larisse Mota Marques; Marcio Viana Ramos Journal: Evid Based Complement Alternat Med Date: 2015-12-14 Impact factor: 2.629
Authors: Kamal A Ketuly; A Hamid A Hadi; Shahram Golbabapour; Maryam Hajrezaie; Pouya Hassandarvish; Hapipah Mohd Ali; Nazia Abdul Majid; Mahmood A Abdulla Journal: PLoS One Date: 2013-03-13 Impact factor: 3.240
Authors: Francisco E B Júnior; Dayanne R de Oliveira; Elizângela B Bento; Laura H I Leite; Daniele O Souza; Ana Luiza A Siebra; Renata S Sampaio; Anita O P B Martins; Andreza G B Ramos; Saulo R Tintino; Luiz J Lacerda-Neto; Patricia R L Figueiredo; Larissa R Oliveira; Cristina K S Rodrigues; Valterlúcio S Sales; Francisco R S D N Figueiredo; Emmily P Nascimento; Alefe B Monteiro; Erika N Amaro; José G M Costa; Henrique Douglas Melo Coutinho; Irwin R A de Menezes; Marta R Kerntopf Journal: Evid Based Complement Alternat Med Date: 2013-06-20 Impact factor: 2.629